Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 126 | 2025 | 1294 | 22.670 |
Why?
|
Aminophenols | 27 | 2024 | 94 | 6.430 |
Why?
|
Quinolones | 24 | 2024 | 389 | 5.430 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 27 | 2024 | 453 | 4.500 |
Why?
|
Benzodioxoles | 16 | 2024 | 80 | 3.790 |
Why?
|
Deoxyribonuclease I | 7 | 2024 | 228 | 1.830 |
Why?
|
Aminopyridines | 6 | 2021 | 580 | 1.760 |
Why?
|
Self Care | 8 | 2017 | 799 | 1.710 |
Why?
|
Achilles Tendon | 4 | 2024 | 181 | 1.310 |
Why?
|
Needs Assessment | 9 | 2021 | 1141 | 1.290 |
Why?
|
Cost of Illness | 7 | 2021 | 1951 | 1.080 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 5 | 2024 | 704 | 1.070 |
Why?
|
Telemedicine | 7 | 2024 | 3109 | 1.070 |
Why?
|
Registries | 14 | 2024 | 8377 | 1.040 |
Why?
|
Forced Expiratory Volume | 13 | 2024 | 1831 | 1.020 |
Why?
|
Parents | 8 | 2019 | 3595 | 0.990 |
Why?
|
Pulmonary Medicine | 3 | 2024 | 223 | 0.950 |
Why?
|
Indoles | 9 | 2024 | 1835 | 0.930 |
Why?
|
Respiratory Function Tests | 12 | 2021 | 1695 | 0.930 |
Why?
|
Thioglycolates | 1 | 2024 | 37 | 0.910 |
Why?
|
Polycyclic Compounds | 1 | 2024 | 28 | 0.910 |
Why?
|
Heel | 1 | 2024 | 38 | 0.900 |
Why?
|
Medication Therapy Management | 2 | 2018 | 131 | 0.860 |
Why?
|
Diterpenes | 1 | 2024 | 169 | 0.840 |
Why?
|
Adolescent | 83 | 2024 | 89155 | 0.830 |
Why?
|
Models, Organizational | 4 | 2021 | 548 | 0.820 |
Why?
|
Continuity of Patient Care | 4 | 2021 | 1078 | 0.810 |
Why?
|
Health Services Accessibility | 8 | 2021 | 5520 | 0.790 |
Why?
|
Child | 68 | 2025 | 80906 | 0.790 |
Why?
|
Chronic Disease | 15 | 2024 | 9384 | 0.780 |
Why?
|
Patient Compliance | 5 | 2017 | 2697 | 0.780 |
Why?
|
Spirometry | 2 | 2022 | 929 | 0.770 |
Why?
|
Communication Barriers | 2 | 2021 | 419 | 0.760 |
Why?
|
Locomotion | 2 | 2024 | 388 | 0.750 |
Why?
|
Lung | 17 | 2022 | 10094 | 0.730 |
Why?
|
Young Adult | 66 | 2024 | 60048 | 0.730 |
Why?
|
Deductibles and Coinsurance | 1 | 2023 | 315 | 0.700 |
Why?
|
Drug Combinations | 8 | 2024 | 2089 | 0.700 |
Why?
|
Insurance Claim Review | 3 | 2018 | 743 | 0.670 |
Why?
|
Walking | 8 | 2024 | 1201 | 0.660 |
Why?
|
Disease Transmission, Infectious | 2 | 2021 | 560 | 0.650 |
Why?
|
Reproductive Health Services | 4 | 2023 | 90 | 0.650 |
Why?
|
Quality of Life | 17 | 2024 | 13489 | 0.640 |
Why?
|
Equipment and Supplies | 1 | 2021 | 274 | 0.640 |
Why?
|
Humans | 167 | 2025 | 767991 | 0.630 |
Why?
|
Adult | 87 | 2025 | 223583 | 0.620 |
Why?
|
Sex Education | 1 | 2019 | 94 | 0.620 |
Why?
|
Running | 1 | 2023 | 490 | 0.600 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2017 | 18 | 0.580 |
Why?
|
Adaptation, Psychological | 4 | 2019 | 2663 | 0.580 |
Why?
|
Pseudomonas Infections | 5 | 2014 | 623 | 0.580 |
Why?
|
Women | 1 | 2018 | 225 | 0.540 |
Why?
|
Asthma | 9 | 2017 | 6273 | 0.510 |
Why?
|
Health Benefit Plans, Employee | 1 | 2018 | 332 | 0.510 |
Why?
|
Disease Progression | 11 | 2022 | 13665 | 0.510 |
Why?
|
Sweat | 4 | 2021 | 57 | 0.490 |
Why?
|
Child Health Services | 1 | 2021 | 645 | 0.490 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 238 | 0.490 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 939 | 0.490 |
Why?
|
Home Care Services | 1 | 2021 | 659 | 0.480 |
Why?
|
Lung Diseases | 3 | 2024 | 1944 | 0.480 |
Why?
|
Tobramycin | 2 | 2012 | 65 | 0.480 |
Why?
|
Male | 101 | 2025 | 364641 | 0.470 |
Why?
|
Eligibility Determination | 1 | 2018 | 421 | 0.470 |
Why?
|
Homozygote | 5 | 2022 | 1778 | 0.470 |
Why?
|
Ethics, Medical | 1 | 2019 | 785 | 0.460 |
Why?
|
Female | 102 | 2025 | 397113 | 0.450 |
Why?
|
Risk Adjustment | 1 | 2018 | 599 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1798 | 0.450 |
Why?
|
Health Status | 6 | 2021 | 4092 | 0.450 |
Why?
|
Treatment Refusal | 1 | 2017 | 433 | 0.440 |
Why?
|
Patient Participation | 2 | 2021 | 1446 | 0.430 |
Why?
|
Health Personnel | 4 | 2023 | 3385 | 0.430 |
Why?
|
Social Perception | 1 | 2017 | 435 | 0.420 |
Why?
|
Cost Savings | 1 | 2018 | 904 | 0.410 |
Why?
|
Quality Improvement | 5 | 2021 | 3855 | 0.410 |
Why?
|
Physician's Role | 1 | 2019 | 925 | 0.410 |
Why?
|
Pseudomonas aeruginosa | 5 | 2019 | 1276 | 0.410 |
Why?
|
Quality of Health Care | 5 | 2021 | 4310 | 0.410 |
Why?
|
Cough | 5 | 2021 | 598 | 0.400 |
Why?
|
Attitude of Health Personnel | 3 | 2023 | 3929 | 0.400 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2024 | 4055 | 0.390 |
Why?
|
Pneumonia | 1 | 2024 | 2163 | 0.390 |
Why?
|
Health Services | 3 | 2016 | 755 | 0.390 |
Why?
|
Health Care Surveys | 2 | 2017 | 2433 | 0.380 |
Why?
|
Ankle Joint | 3 | 2024 | 452 | 0.380 |
Why?
|
Teaching | 1 | 2019 | 1171 | 0.370 |
Why?
|
Self Concept | 1 | 2017 | 1043 | 0.360 |
Why?
|
Pyrazoles | 4 | 2024 | 2028 | 0.360 |
Why?
|
Muscle, Skeletal | 6 | 2024 | 4978 | 0.360 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1667 | 0.360 |
Why?
|
Ambulatory Care | 2 | 2021 | 2781 | 0.350 |
Why?
|
United States | 31 | 2024 | 73027 | 0.350 |
Why?
|
Resilience, Psychological | 1 | 2018 | 807 | 0.350 |
Why?
|
Anti-Asthmatic Agents | 2 | 2017 | 572 | 0.340 |
Why?
|
Recombinant Proteins | 5 | 2024 | 6515 | 0.340 |
Why?
|
Severity of Illness Index | 13 | 2021 | 15944 | 0.340 |
Why?
|
Staphylococcal Infections | 2 | 2009 | 1398 | 0.340 |
Why?
|
Anti-Bacterial Agents | 7 | 2024 | 7470 | 0.330 |
Why?
|
Sexual Behavior | 7 | 2022 | 2197 | 0.310 |
Why?
|
Qualitative Research | 4 | 2025 | 3140 | 0.310 |
Why?
|
Women's Health | 1 | 2018 | 2082 | 0.300 |
Why?
|
Caregivers | 5 | 2024 | 2302 | 0.300 |
Why?
|
Drug Costs | 2 | 2013 | 1195 | 0.290 |
Why?
|
Patient Advocacy | 1 | 2009 | 362 | 0.280 |
Why?
|
Child, Preschool | 26 | 2025 | 42665 | 0.280 |
Why?
|
Sinusitis | 3 | 2021 | 997 | 0.280 |
Why?
|
Advance Directives | 1 | 2008 | 249 | 0.270 |
Why?
|
Health Expenditures | 2 | 2018 | 2389 | 0.270 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2021 | 84 | 0.260 |
Why?
|
Mutation | 14 | 2023 | 30211 | 0.260 |
Why?
|
Time | 3 | 2021 | 552 | 0.260 |
Why?
|
Gait | 4 | 2024 | 823 | 0.260 |
Why?
|
Prescription Drugs | 1 | 2013 | 635 | 0.250 |
Why?
|
Adrenal Cortex Hormones | 2 | 2017 | 1883 | 0.250 |
Why?
|
Pyridines | 4 | 2024 | 2893 | 0.250 |
Why?
|
Hypoglycemia | 2 | 2024 | 895 | 0.250 |
Why?
|
Administration, Inhalation | 4 | 2017 | 1169 | 0.250 |
Why?
|
Longitudinal Studies | 14 | 2021 | 14783 | 0.240 |
Why?
|
Pneumonia, Bacterial | 1 | 2008 | 320 | 0.240 |
Why?
|
Counseling | 2 | 2017 | 1554 | 0.240 |
Why?
|
Hospitalization | 6 | 2019 | 10840 | 0.230 |
Why?
|
Torque | 1 | 2024 | 132 | 0.230 |
Why?
|
Health Services Needs and Demand | 4 | 2021 | 1406 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2024 | 1388 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18407 | 0.230 |
Why?
|
Muscle Spindles | 1 | 2023 | 15 | 0.230 |
Why?
|
Motivation | 1 | 2014 | 2020 | 0.220 |
Why?
|
Employment | 1 | 2010 | 1110 | 0.220 |
Why?
|
Pediatrics | 8 | 2024 | 3629 | 0.220 |
Why?
|
Men's Health | 2 | 2022 | 75 | 0.220 |
Why?
|
Perception | 1 | 2010 | 1209 | 0.220 |
Why?
|
Costs and Cost Analysis | 3 | 2021 | 1666 | 0.220 |
Why?
|
Tablets | 1 | 2024 | 149 | 0.220 |
Why?
|
Glucocorticoids | 1 | 2013 | 2166 | 0.220 |
Why?
|
Shoes | 1 | 2024 | 91 | 0.220 |
Why?
|
Postural Balance | 2 | 2024 | 639 | 0.210 |
Why?
|
Steroids | 1 | 2008 | 938 | 0.200 |
Why?
|
Fatigue | 2 | 2021 | 1557 | 0.200 |
Why?
|
Tendons | 2 | 2023 | 556 | 0.200 |
Why?
|
Rhinitis | 2 | 2021 | 753 | 0.200 |
Why?
|
Feedback, Physiological | 1 | 2024 | 482 | 0.200 |
Why?
|
Radius | 2 | 2016 | 443 | 0.200 |
Why?
|
Education, Medical | 1 | 2014 | 1742 | 0.200 |
Why?
|
Interviews as Topic | 4 | 2025 | 2741 | 0.200 |
Why?
|
Pyrrolidines | 4 | 2024 | 340 | 0.200 |
Why?
|
Swimming | 1 | 2023 | 209 | 0.190 |
Why?
|
Gait Disorders, Neurologic | 1 | 2024 | 243 | 0.190 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2336 | 0.190 |
Why?
|
Self Report | 4 | 2024 | 3773 | 0.190 |
Why?
|
Comparative Effectiveness Research | 2 | 2018 | 714 | 0.190 |
Why?
|
Muscles | 2 | 2023 | 1582 | 0.190 |
Why?
|
Health Policy | 1 | 2014 | 2698 | 0.190 |
Why?
|
Gastrostomy | 1 | 2024 | 325 | 0.180 |
Why?
|
Respiratory Tract Infections | 3 | 2021 | 1014 | 0.180 |
Why?
|
Advance Care Planning | 1 | 2008 | 698 | 0.180 |
Why?
|
Social Support | 3 | 2019 | 2193 | 0.180 |
Why?
|
Sickness Impact Profile | 2 | 2012 | 299 | 0.180 |
Why?
|
Oximetry | 2 | 2021 | 462 | 0.170 |
Why?
|
Milk, Human | 1 | 2025 | 490 | 0.170 |
Why?
|
Bone Density | 3 | 2021 | 3573 | 0.170 |
Why?
|
Dyspnea | 1 | 2008 | 1352 | 0.170 |
Why?
|
Treatment Outcome | 14 | 2024 | 65364 | 0.160 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 475 | 0.160 |
Why?
|
Retrospective Studies | 17 | 2021 | 81746 | 0.160 |
Why?
|
Saline Solution, Hypertonic | 3 | 2024 | 115 | 0.160 |
Why?
|
Neonatal Screening | 1 | 2024 | 620 | 0.160 |
Why?
|
Insurance, Health | 3 | 2023 | 2517 | 0.160 |
Why?
|
Tibia | 2 | 2016 | 1076 | 0.160 |
Why?
|
Awards and Prizes | 1 | 2023 | 365 | 0.160 |
Why?
|
Insurance Coverage | 2 | 2023 | 1946 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1088 | 0.160 |
Why?
|
Fees, Pharmaceutical | 1 | 2018 | 66 | 0.160 |
Why?
|
Interdisciplinary Studies | 1 | 2019 | 86 | 0.160 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26375 | 0.160 |
Why?
|
Crohn Disease | 2 | 2021 | 2295 | 0.150 |
Why?
|
Paranasal Sinuses | 2 | 2021 | 267 | 0.150 |
Why?
|
Organizational Innovation | 1 | 2021 | 540 | 0.150 |
Why?
|
Middle Aged | 24 | 2024 | 223422 | 0.150 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1671 | 0.150 |
Why?
|
Behavior Therapy | 1 | 2024 | 886 | 0.150 |
Why?
|
Hospitals, Pediatric | 3 | 2021 | 1874 | 0.150 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2021 | 497 | 0.150 |
Why?
|
Unemployment | 1 | 2019 | 211 | 0.150 |
Why?
|
Radiography, Thoracic | 2 | 2015 | 1321 | 0.150 |
Why?
|
Medication Adherence | 3 | 2024 | 2187 | 0.140 |
Why?
|
Enteral Nutrition | 1 | 2024 | 802 | 0.140 |
Why?
|
Body Image | 1 | 2022 | 646 | 0.140 |
Why?
|
Decision Making | 2 | 2024 | 3952 | 0.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1232 | 0.140 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2107 | 0.140 |
Why?
|
Chlorides | 2 | 2021 | 666 | 0.140 |
Why?
|
Nutritional Status | 2 | 2015 | 1628 | 0.140 |
Why?
|
Anxiety | 4 | 2021 | 4672 | 0.140 |
Why?
|
Drug Administration Schedule | 3 | 2016 | 4857 | 0.140 |
Why?
|
Infant | 13 | 2025 | 36534 | 0.140 |
Why?
|
Health Surveys | 3 | 2019 | 4056 | 0.140 |
Why?
|
Cephalosporins | 1 | 2017 | 200 | 0.130 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2442 | 0.130 |
Why?
|
Ibuprofen | 1 | 2018 | 229 | 0.130 |
Why?
|
Emigration and Immigration | 1 | 2019 | 406 | 0.130 |
Why?
|
Efficiency | 1 | 2019 | 479 | 0.130 |
Why?
|
Pancreas | 2 | 2024 | 1700 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 670 | 0.130 |
Why?
|
Sex Factors | 5 | 2021 | 10627 | 0.130 |
Why?
|
Pharmacies | 1 | 2018 | 171 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2023 | 1656 | 0.130 |
Why?
|
Airway Resistance | 1 | 2017 | 407 | 0.130 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2017 | 1188 | 0.130 |
Why?
|
Prescriptions | 1 | 2018 | 388 | 0.120 |
Why?
|
Communication | 3 | 2018 | 3904 | 0.120 |
Why?
|
Logistic Models | 4 | 2015 | 13289 | 0.120 |
Why?
|
Health Services Misuse | 1 | 2017 | 246 | 0.120 |
Why?
|
Health Status Indicators | 1 | 2021 | 969 | 0.120 |
Why?
|
Public Policy | 1 | 2019 | 552 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 779 | 0.120 |
Why?
|
Eating | 1 | 2022 | 1542 | 0.120 |
Why?
|
Cohort Studies | 8 | 2021 | 41749 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1388 | 0.120 |
Why?
|
Sampling Studies | 2 | 2014 | 615 | 0.120 |
Why?
|
Contraception | 1 | 2018 | 362 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Knee Joint | 1 | 2023 | 1683 | 0.120 |
Why?
|
Nebulizers and Vaporizers | 1 | 2015 | 139 | 0.120 |
Why?
|
Terminal Care | 2 | 2017 | 1770 | 0.110 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6314 | 0.110 |
Why?
|
Directive Counseling | 1 | 2015 | 171 | 0.110 |
Why?
|
Mothers | 1 | 2025 | 2209 | 0.110 |
Why?
|
Follow-Up Studies | 8 | 2024 | 39345 | 0.110 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2018 | 463 | 0.110 |
Why?
|
Fertility | 1 | 2018 | 771 | 0.110 |
Why?
|
Adolescent Medicine | 1 | 2014 | 73 | 0.110 |
Why?
|
Adolescent Health Services | 1 | 2015 | 220 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20218 | 0.110 |
Why?
|
Infant, Newborn | 4 | 2024 | 26420 | 0.110 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2429 | 0.110 |
Why?
|
Physician-Patient Relations | 3 | 2011 | 3269 | 0.100 |
Why?
|
Forecasting | 2 | 2014 | 2945 | 0.100 |
Why?
|
Databases, Factual | 2 | 2019 | 8082 | 0.100 |
Why?
|
Program Development | 1 | 2019 | 1299 | 0.100 |
Why?
|
Time Factors | 4 | 2021 | 40214 | 0.100 |
Why?
|
Mechanical Phenomena | 2 | 2024 | 143 | 0.100 |
Why?
|
Airway Obstruction | 1 | 2017 | 672 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8052 | 0.100 |
Why?
|
Medically Uninsured | 1 | 2018 | 840 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1059 | 0.100 |
Why?
|
Body Composition | 1 | 2022 | 2462 | 0.100 |
Why?
|
Survivors | 2 | 2016 | 2381 | 0.100 |
Why?
|
Program Evaluation | 2 | 2018 | 2506 | 0.100 |
Why?
|
Elasticity Imaging Techniques | 1 | 2017 | 398 | 0.100 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5366 | 0.100 |
Why?
|
Otolaryngology | 1 | 2019 | 699 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12075 | 0.100 |
Why?
|
Genotype | 3 | 2021 | 13042 | 0.100 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3488 | 0.090 |
Why?
|
Propensity Score | 2 | 2018 | 1970 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2022 | 5314 | 0.090 |
Why?
|
Factor Analysis, Statistical | 2 | 2014 | 1001 | 0.090 |
Why?
|
Aging | 3 | 2024 | 8744 | 0.090 |
Why?
|
Vocational Guidance | 1 | 2010 | 14 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 905 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1854 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1598 | 0.090 |
Why?
|
Palliative Care | 2 | 2017 | 3642 | 0.090 |
Why?
|
Nut Hypersensitivity | 1 | 2010 | 33 | 0.090 |
Why?
|
Egg Hypersensitivity | 1 | 2010 | 47 | 0.090 |
Why?
|
Depression | 3 | 2020 | 8231 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2022 | 3205 | 0.090 |
Why?
|
Ventilator Weaning | 1 | 2011 | 170 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 702 | 0.090 |
Why?
|
Bone and Bones | 1 | 2021 | 2589 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 557 | 0.090 |
Why?
|
Patients | 2 | 2014 | 908 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2022 | 3329 | 0.080 |
Why?
|
Confidentiality | 1 | 2014 | 607 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 830 | 0.080 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2016 | 783 | 0.080 |
Why?
|
Professional Practice | 1 | 2011 | 314 | 0.080 |
Why?
|
Inhalation | 1 | 2010 | 145 | 0.080 |
Why?
|
Foundations | 2 | 2020 | 96 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5884 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1565 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3447 | 0.080 |
Why?
|
Boston | 4 | 2015 | 9368 | 0.080 |
Why?
|
Weight Gain | 1 | 2019 | 2359 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1926 | 0.080 |
Why?
|
Blood Glucose | 4 | 2024 | 6429 | 0.070 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 418 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2271 | 0.070 |
Why?
|
Respiratory Therapy | 1 | 2008 | 125 | 0.070 |
Why?
|
Ion Channel Gating | 2 | 2021 | 429 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2017 | 1309 | 0.070 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2011 | 329 | 0.070 |
Why?
|
Transportation | 1 | 2009 | 217 | 0.070 |
Why?
|
Body Mass Index | 4 | 2022 | 13053 | 0.070 |
Why?
|
Absorptiometry, Photon | 3 | 2022 | 1758 | 0.070 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 109 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2022 | 12464 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4258 | 0.070 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2007 | 91 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1444 | 0.070 |
Why?
|
Case-Control Studies | 5 | 2022 | 22287 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3231 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1885 | 0.070 |
Why?
|
Internal Medicine | 1 | 2014 | 1064 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1960 | 0.070 |
Why?
|
Exercise | 2 | 2022 | 5955 | 0.070 |
Why?
|
Family Relations | 1 | 2008 | 318 | 0.070 |
Why?
|
Vital Capacity | 2 | 2021 | 996 | 0.060 |
Why?
|
Bacteria | 1 | 2017 | 2216 | 0.060 |
Why?
|
Massachusetts | 4 | 2014 | 8888 | 0.060 |
Why?
|
Survival Analysis | 3 | 2018 | 10098 | 0.060 |
Why?
|
Self Efficacy | 1 | 2009 | 643 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10757 | 0.060 |
Why?
|
Aged | 11 | 2024 | 171446 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5887 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.060 |
Why?
|
Attitude to Health | 1 | 2014 | 2024 | 0.060 |
Why?
|
Affective Symptoms | 1 | 2008 | 418 | 0.060 |
Why?
|
Prospective Studies | 7 | 2024 | 54924 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4628 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1126 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1210 | 0.060 |
Why?
|
Pregnancy Rate | 2 | 2017 | 655 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2011 | 836 | 0.060 |
Why?
|
Bionics | 1 | 2024 | 46 | 0.060 |
Why?
|
Treatment Failure | 1 | 2010 | 2660 | 0.060 |
Why?
|
Medicaid | 1 | 2017 | 2840 | 0.060 |
Why?
|
Physicians | 4 | 2017 | 4598 | 0.060 |
Why?
|
Necrosis | 1 | 2008 | 1616 | 0.050 |
Why?
|
Prevalence | 4 | 2021 | 15867 | 0.050 |
Why?
|
Risk Factors | 5 | 2018 | 74936 | 0.050 |
Why?
|
Biofeedback, Psychology | 1 | 2023 | 117 | 0.050 |
Why?
|
Data Collection | 2 | 2011 | 3326 | 0.050 |
Why?
|
Drug Monitoring | 2 | 2019 | 964 | 0.050 |
Why?
|
Insulin Infusion Systems | 1 | 2024 | 221 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1183 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2062 | 0.050 |
Why?
|
Knee | 1 | 2023 | 277 | 0.050 |
Why?
|
Cardiology | 1 | 2012 | 1702 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8748 | 0.050 |
Why?
|
Contraceptive Agents | 1 | 2022 | 148 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2021 | 125 | 0.050 |
Why?
|
Family | 2 | 2011 | 3210 | 0.040 |
Why?
|
Schools | 1 | 2009 | 1498 | 0.040 |
Why?
|
Regression Analysis | 1 | 2009 | 6339 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2726 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2008 | 6228 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3463 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6211 | 0.040 |
Why?
|
Electromyography | 1 | 2024 | 1399 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16723 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2019 | 152 | 0.040 |
Why?
|
Posture | 1 | 2023 | 957 | 0.040 |
Why?
|
Quinolines | 1 | 2024 | 770 | 0.040 |
Why?
|
Risk Assessment | 2 | 2018 | 24314 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1142 | 0.040 |
Why?
|
Otitis Media | 1 | 2021 | 288 | 0.040 |
Why?
|
Biological Availability | 1 | 2019 | 389 | 0.040 |
Why?
|
Israel | 1 | 2021 | 726 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 565 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4746 | 0.040 |
Why?
|
Transaminases | 1 | 2019 | 199 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1123 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1880 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12536 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4857 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12252 | 0.040 |
Why?
|
Diet Surveys | 1 | 2022 | 1160 | 0.040 |
Why?
|
Vomiting | 1 | 2021 | 655 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 291 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 526 | 0.040 |
Why?
|
Mental Disorders | 1 | 2017 | 6875 | 0.040 |
Why?
|
Germany | 1 | 2019 | 883 | 0.040 |
Why?
|
North America | 1 | 2021 | 1289 | 0.040 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2017 | 75 | 0.040 |
Why?
|
Australia | 1 | 2021 | 1265 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2010 | 5536 | 0.030 |
Why?
|
Health Care Costs | 1 | 2010 | 3239 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2019 | 584 | 0.030 |
Why?
|
Family Health | 1 | 2021 | 1255 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2016 | 20757 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 651 | 0.030 |
Why?
|
Movement | 1 | 2023 | 1490 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
Breast Feeding | 1 | 2025 | 1363 | 0.030 |
Why?
|
Postoperative Period | 1 | 2021 | 1826 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2012 | 4713 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1997 | 354 | 0.030 |
Why?
|
Audiometry | 1 | 2016 | 253 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1216 | 0.030 |
Why?
|
Self-Assessment | 1 | 2017 | 400 | 0.030 |
Why?
|
Obesity | 1 | 2017 | 13091 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1754 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12828 | 0.030 |
Why?
|
New England | 1 | 2017 | 1058 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3437 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7851 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 996 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 303 | 0.030 |
Why?
|
North Carolina | 1 | 2014 | 329 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15442 | 0.030 |
Why?
|
Hemoptysis | 1 | 2014 | 152 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2908 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6894 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1613 | 0.030 |
Why?
|
Pregnancy | 3 | 2022 | 30260 | 0.030 |
Why?
|
Immunophenotyping | 1 | 1997 | 1863 | 0.030 |
Why?
|
Sputum | 1 | 2014 | 516 | 0.020 |
Why?
|
Psychometrics | 2 | 2012 | 3062 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1736 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2021 | 2592 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 1997 | 1418 | 0.020 |
Why?
|
Age Distribution | 1 | 2017 | 2871 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 1967 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3108 | 0.020 |
Why?
|
Vitamin D | 2 | 2015 | 3311 | 0.020 |
Why?
|
Esophageal pH Monitoring | 1 | 2011 | 203 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7939 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3347 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2202 | 0.020 |
Why?
|
Vital Signs | 1 | 2011 | 145 | 0.020 |
Why?
|
Prognosis | 3 | 2019 | 29979 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1815 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10590 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6606 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14718 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3628 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1430 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2211 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2012 | 3619 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6517 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 392 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2618 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2014 | 1497 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4030 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22365 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2017 | 1467 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2487 | 0.020 |
Why?
|
Vitamins | 1 | 2015 | 1638 | 0.020 |
Why?
|
Proton Pump Inhibitors | 1 | 2011 | 551 | 0.020 |
Why?
|
Community Health Centers | 1 | 2010 | 469 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3886 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2533 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8740 | 0.010 |
Why?
|
Poverty | 1 | 2015 | 2720 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2721 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2011 | 1240 | 0.010 |
Why?
|
Cytokines | 1 | 1997 | 7450 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9666 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3858 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4564 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5458 | 0.010 |
Why?
|
Curriculum | 1 | 2015 | 3782 | 0.010 |
Why?
|
Patient Care Team | 1 | 2011 | 2521 | 0.010 |
Why?
|
Premature Birth | 1 | 2011 | 1829 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2054 | 0.010 |
Why?
|
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1997 | 15 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1997 | 40 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 2736 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10871 | 0.010 |
Why?
|
Clone Cells | 1 | 1997 | 1669 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 13000 | 0.010 |
Why?
|
Cell Line | 1 | 1997 | 15597 | 0.000 |
Why?
|